Johnson & Johnson’s $16.6bn Acquisition of Abiomed
By William Dinsdale and Bilal Rashid (LSE), Priyanshu Srivastava and Deepankumar Sakthive (Warwick) Photo: Jesse Orrico (Unsplash)...
- Nov 7
- 4 min
CVS’ $8bn Acquisition of Signify Health
By William Dinsdale and Bilal Rashid (LSE), Friedrich von Storch, Enrique Perez-Hernandez and Ties Oudmayer (IE) Photo: Nathaniel Yeo...
- Oct 31
- 5 min
Kroger’s $24.6bn Acquisition of Albertsons
By Matilda Oculy and Filip Stoilov (University of Manchester), Sameer Jain and Micheal Akullo (Wharton School) Photo: No Revisions...
- Oct 19
- 5 min
Amazon’s $3.9bn Acquisition of One Medical
By Jack Lee, Heather Leung and Terry Au-Yeung (HKUST), Sonia Andrzejuk, Argyro Charizona and Vlad Marcu (Bocconi) Photo: Hyttalo Souza...
- Sep 12
- 4 min
Novartis’ spin-off of Sandoz business
By Sameer Jain (Wharton School), Eden Yang (London School of Economics) Photo: Freestocks (Unsplash) Overview of the deal Parent:...
- Jun 12
- 4 min
Pfizer $11.6bn Acquisition of Biohaven
By Justin Leung, Jack Lee, Heather Leung, and Sissi Zeng (Hong Kong University of Science and Technology) Photo: Christina Victoria...
- Jan 26
- 4 min
Stryker’s $3.09bn Acquisition of Vocera Communications
By Matilda Oculy, Aadit Jain, András Szabó, and Deimantė Chailenko (Manchester), Joshua Ooi, Ayushman Nath, Danissa Wan, Jack Wu, and...
- Oct 13, 2021
- 5 min
Merck’s $11.5bn Acquisition of Acceleron Pharma
By Tudor Popescu and Bella Chen (University of Chicago), Ivan Chung, Justin Leung, and Ryan Chan (HKUST) Photo: Louis Reed (Unsplash)...
- Mar 10, 2021
- 4 min
Sanofi’s Acquisition of Kymab
By Lorenzo Mirone, Riccardo Colombo, Federico de Rosa (Bocconi University) and Roshni Padhi, Winston Shum, Moh Jin Yin (Stanford...
- Feb 23, 2021
- 5 min
Jazz Pharmaceuticals’ $7.2bn Acquisition of GW Pharmaceuticals
By Edvard Bruu and Hannah Ohlsson (Stockholm School of Economics), Isabelle Duerbeck and Tim Bamberger (King’s College London) Photo:...
- Feb 1, 2021
- 7 min
Pharmaceutical M&A
By Gurneek Gill (UCL), Nihat Anwar (SSE), Mustafa Bayramli (Wharton) Photo: Myriam Zilles (Unsplash) I. Industry Background The...
- Jan 12, 2021
- 4 min
AstraZeneca to acquire Alexion in $39bn deal
By Itai Almogy, Gaspard Baroudel, Raphael Berz (Yale University), and Nathan Walemba (Oxford University) Photo: Julia Koblitz (Unsplash)...
- Oct 5, 2020
- 4 min
Illumina’s $8bn Acquisition of GRAIL
By Vinay Naik (University of Warwick), Roshni Padhi, Amarins Laanstra-Corn and Winston Shum (Stanford University) Overview of the deal...
- Sep 28, 2020
- 5 min
Gilead Sciences Inc.’s $21bn Acquisition of Immunomedics
By Jinghan Jennifer, Sanjana Ramaswamy, William Zhang (St Andrews), Mariana Velasco, Anthony Borgese, Mustafa Bayramli, Susan Xiao & Zen...
- Sep 14, 2020
- 4 min
Nestlé's $2.6 Billion Acquisition of Aimmune Therapeutics
By Edvard Bruu and Wilma Tillqvist (Stockholm School of Economics), Aman Singla, Akhil Anand Vajjhala and Siddharth Tripurani (New York...
- Sep 5, 2020
- 10 min
Teladoc Health and Livongo Merger
By: AJ Tomas (University of Chicago), Demi Akinjide, Saihejpal Ailwadhi, Ben Fobel, Zac Greenberg (University of Bristol) Overview of the...
- Sep 7, 2019
- 7 min
Mylan’s Merger with Pfizer’s Upjohn Unit
Pfizer’s UpJohn franchise is merging with Mylan- the troubled EpiPen manufacturer shrouded in price fixing controversies.
- Jul 27, 2019
- 7 min
AbbVie’s $63 billion Acquisition of Allergan
US drugmaker AbbVie launched a $63 billion bid for Botox maker Allergan in what will result in the world’s fifth largest drug company.
- Jun 15, 2019
- 5 min
Danaher $21.4bn acquisition of General Electric’s Life Sciences division
General Electric sold its Life Sciences division to Danaher Corporation for $21.4bn, as part of GE's plan to push further its aviation.
- May 8, 2019
- 4 min
Roche’s $4.3 billion acquisition of Spark
Roche, the Swiss drugs group, has won a two-way race to acquire Spark Therapeutics, Inc. for $4.8bn.
- Mar 13, 2019
- 4 min
Merck’s $2.4bn acquisition of Antelliq
Merck's strategic acquisition of Antelliq leads the path to sustainable and significant investments in agricultural technologies.
- Mar 9, 2019
- 5 min
Eli Lilly’s $8bn Acquisition of Loxo Oncology
Eli Lilly’s most recent acquisition marks a clear strategic path towards immunotherapy and oncology for the firm.
- Mar 2, 2019
- 5 min
Johnson and Johnson’s $3.4bn acquisition of Auris Health
Amidst a pharma spending spree, Johnson & Johnson $3.4bn acquisition of Auris Health is a move towards turning around its medical devices.
- Feb 13, 2019
- 6 min
Cigna’s $70bn acquisition of Express Scripts Holding Co.
Cigna’s $70bn acquisition of Express Scripts was the biggest deal by volume announced in 2018, but was it the smartest?
- Jan 26, 2019
- 5 min
Bristol-Myers Squibb’s $74bn Acquisition of Celgene
This deal will allow the biopharmaceutical giant to diversify its drug portfolio and stay on the cutting edge of experimental therapy.
- Oct 26, 2018
- 4 min
LifePoint Health’s $5.6 bn Merger with RCCH HealthCare Partners
By Carlos Asorey (Georgetown University) 26/10/2018 | Overview of the deal Acquirer: RCCH HealthCare Partners Target: LifePoint Health...
- Jun 18, 2018
- 5 min
Takeda’s $62 billion Acquisition of Shire
Overview of the deal Acquirer: Takeda Target: Shire Estimated value: $62 bn Announcement date: 08/05/18 Takeda Advisors: Evercore, JP...
- Mar 26, 2018
- 4 min
Bayer’s $66 billion Acquisition of Monsanto
Overview of the deal Acquirer: Bayer Target: Monsanto Estimated value: $66 billion Announcement date: May 2016 Acquirer Advisors: Credit...
- Mar 12, 2018
- 5 min
Sanofi’s proposed $11.6 billion Acquisition of Bioverativ
Overview of the deal Acquirer: Sanofi SA (Paris: SAN) Target: Bioverativ. (NASDAQ: BIVV) Estimated value: $11.6bn Announcement date: 3/12...
- Feb 27, 2018
- 4 min
Luxottica and Essilor agree $54bn merger
Overview of the deal Initiating firm: Essilor Approached firm: Luxottica Estimated value: $54 Bn (including net debt) Announcement:...
- Feb 15, 2018
- 4 min
CVS Health’s $77 billion acquisition of Aetna
Overview of the deal Acquirer: CVS Health Corporation (NYSE: CVS) Target: Aetna Inc. (NYSE: AET) Estimated value: $69bn ($77bn including...
